# Merz Pharma GmbH & Co., KGaA - Inspection Records

Source: https://www.keypedia.com/companies/merz-pharma-gmbh-co-kgaa/758203de-10f2-4cff-a0ca-d3b1152277c0

> Inspection records and compliance data for Merz Pharma GmbH & Co., KGaA in Dessau-Rosslau, None. Access full analysis and detailed observations.

---

## Details

- Name: Merz Pharma GmbH & Co., KGaA
- FEI Number: 3006896175
- City: Dessau-Rosslau
- State: None
- Country Name: Germany
- Address Line 1: Am Pharmapark
- Zip Code: None

## Related Documents

- [FDA Inspection 1250812 - Merz Pharma GmbH & Co., KGaA - 2022-06-29](https://www.keypedia.com/records/fda_inspections/merz-pharma-gmbh-co-kgaa/c721573c-9a4b-47b8-b6b8-a142758af13d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 29, 2022
- [EIR - Merz Pharma GmbH & Co., KGaA - 2019-11-22](https://www.keypedia.com/records/eir/merz-pharma-gmbh-co-kgaa/fbb54621-94f6-429f-a1fb-cd547c6d5762) — source: FDA, date: November 22, 2019
- [483 - Merz Pharma GmbH & Co., KGaA - 2019-11-22](https://www.keypedia.com/records/483/merz-pharma-gmbh-co-kgaa/f531c972-160a-4e9f-97ff-9b11868ea634) — source: FDA, date: November 22, 2019
- [FDA Inspection 1021141 - Merz Pharma GmbH & Co., KGaA - 2017-07-04](https://www.keypedia.com/records/fda_inspections/merz-pharma-gmbh-co-kgaa/c753b773-c4fd-403c-8c66-d824651e0b65) — classification: No Action Indicated (NAI), source: FDA, date: July 4, 2017
- [FDA Inspection 945417 - Merz Pharma GmbH & Co., KGaA - 2015-09-15](https://www.keypedia.com/records/fda_inspections/merz-pharma-gmbh-co-kgaa/e20f5a65-91f1-4e72-9384-34cb5daaa65a) — classification: No Action Indicated (NAI), source: FDA, date: September 15, 2015
- [FDA Inspection 853048 - Merz Pharma GmbH & Co., KGaA - 2013-09-25](https://www.keypedia.com/records/fda_inspections/merz-pharma-gmbh-co-kgaa/ea4d421e-ca45-47b6-830a-b20f2541ac1a) — classification: No Action Indicated (NAI), source: FDA, date: September 25, 2013
- [FDA Inspection 773481 - Merz Pharma GmbH & Co., KGaA - 2011-10-28](https://www.keypedia.com/records/fda_inspections/merz-pharma-gmbh-co-kgaa/1ee2d2ce-f1ee-4968-88df-886ec1331cf9) — classification: No Action Indicated (NAI), source: FDA, date: October 28, 2011

## Related Companies

- [Immunex Rhode Island Corporation](https://www.keypedia.com/companies/immunex-rhode-island-corporation/c70ebfcc-0c4d-4294-845a-24f1af8f30e9)
- [Sucampo Pharma, LLC](https://www.keypedia.com/companies/sucampo-pharma-llc/5a5bffc7-663f-47ab-8ccf-2078e2f49f60)
- [Taixing SynTheAll Pharmaceutical Co., Ltd](https://www.keypedia.com/companies/taixing-syntheall-pharmaceutical-co-ltd/7acaa1ac-b9fc-4fed-8ac5-a6b413bdf3e1)
- [Amgen Singapore Manufacturing Pte Ltd](https://www.keypedia.com/companies/amgen-singapore-manufacturing-pte-ltd/ff869a15-a7c2-441a-8165-7fd77928331e)
- [Alk-abello A/s](https://www.keypedia.com/companies/alk-abello-as/40a1685c-dc02-464f-a52b-4678d31929ed)
- [Janssen Biotech, Inc.](https://www.keypedia.com/companies/janssen-biotech-inc/5374365d-a0df-4a87-ad3d-2714628d3e57)
- [Wyeth Pharmaceutical Division of Wyeth Holdings LLC](https://www.keypedia.com/companies/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/85fd73c7-1b97-4ac5-bc70-53dfb31c37e5)
- [Laurus Labs Limited](https://www.keypedia.com/companies/laurus-labs-limited/4112e7fd-7d8d-41bc-914f-6c705b2e47c7)
- [Baxalta US Incorporated](https://www.keypedia.com/companies/baxalta-us-incorporated/bb2b5b07-7c9c-4fce-b969-4dc5fa402b64)
- [AbbVie Bioresearch Center](https://www.keypedia.com/companies/abbvie-bioresearch-center/6957449c-4de8-444b-b53c-5838b33a76a1)

## Related Officers

- [Supervisory Consumer Safety Officer](https://www.keypedia.com/people/mark-c-saale/0e5af086-8319-4499-878e-5bd94e66ea69)
- [Yumi Hiramine](https://www.keypedia.com/people/yumi-hiramine/26c5059f-8f61-42cf-ae79-65a7b942d2c7)
- [Microbiologist](https://www.keypedia.com/people/susan-t-hadman/512c3274-4da8-4f5a-a081-965ab5ec84e6)